Product Information
FLAVOXATE HCL 100 MG TABLET is a generic product labeled by Padagis US LLC, priced at $0.3894 per EA under NDC 00574011501. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 16, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
100 mg/1
Manufacturer
Padagis US LLCNDC
00574011501
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLAVOXATE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076831FDA Approved
12/16/2004
TE Code
AB
On Market Since
12/22/2004
Pharmacological Classes
Price Statistics
The NADAC for FLAVOXATE HCL 100 MG TABLET has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3894 per EA |
|---|---|
| All-time high | $0.9005 (Sep 16, 2020) |
| All-time low | $0.3894 (Sep 23, 2026) |
| 52-week high | $0.8142 |
| 52-week low | $0.3894 |
| Median price | $0.7015 |
| Average price | $0.6984 |
| Largest weekly change | -35.3% (Sep 23, 2020) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FLAVOXATE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Padagis US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FLAVOXATE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cholinergic Muscarinic Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLAVOXATE HCL 100 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FLAVOXATE HCL 100 MG TABLET, manufactured by Padagis US LLC, is $0.3894 per EA (NDC 00574011501), effective Sep 30, 2026.
How has the price of FLAVOXATE HCL 100 MG TABLET changed over time?
Over the history we have for it, the NADAC for FLAVOXATE HCL 100 MG TABLET has declined 50.7%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLAVOXATE HCL 100 MG TABLET?
Since Nov 28, 2013, the NADAC for FLAVOXATE HCL 100 MG TABLET has ranged from a low of $0.3894 (Sep 23, 2026) to a high of $0.9005 (Sep 16, 2020), with a median of $0.7015 per EA.
Are there cheaper alternatives to FLAVOXATE HCL 100 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of FLAVOXATE HCL 100 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FLAVOXATE HCL 100 MG TABLET?
FLAVOXATE HCL 100 MG TABLET (NDC 00574011501) is labeled by Padagis US LLC, and CMS classifies it as a generic product.